Department of Dermatology, Far Eastern Memorial Hospital, New Taipei City, Taiwan; Graduate Institute of Applied Science and Engineering, College of Science and Engineering, Fu Jen Catholic University, New Taipei City, Taiwan.
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
J Am Acad Dermatol. 2019 Apr;80(4):1006-1012. doi: 10.1016/j.jaad.2018.11.049. Epub 2018 Dec 5.
The association between psoriasis and thyroid diseases is unclear.
To examine the risk for thyroid diseases among psoriasis patients.
We used Taiwan's National Health Insurance Research Database to conduct a nationwide cohort study. We examined the adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for incident thyroid diseases in relation to psoriasis and psoriatic arthritis.
We identified 13,266 patients with psoriatic arthritis (psoriatic arthritis group), 149,576 with psoriasis alone (psoriasis group), and 162,842 nonpsoriasis controls. Compared with the nonpsoriasis controls, the psoriatic arthritis and psoriasis groups had increased risk for incident hyperthyroidism (aHR 1.32, 95% CI 1.07-1.65 [psoriatic arthritis]; aHR 1.22, 95% CI 1.11-1.33 [psoriasis]) and Graves disease (aHR 1.38, 95% CI 1.07-1.79 [psoriatic arthritis]; aHR 1.26, 95% CI 1.13-1.41 [psoriasis]). Both groups also had increased risk for incident hypothyroidism (aHR 1.74, 95% CI 1.34-2.27 [psoriatic arthritis]; aHR 1.38, 95% CI 1.23-1.56 [psoriasis]) and Hashimoto thyroiditis (aHR 2.09, 95% CI 1.34-3.24 [psoriatic arthritis]; aHR 1.47, 95% CI 1.18-1.82 [psoriasis]).
Lack of data on psoriasis severity.
People with psoriatic disease are associated with an increased incident thyroid diseases, including hyperthyroidism, hypothyroidism, thyroiditis, Graves disease, and Hashimoto thyroiditis. Endocrinology consultation may be considered when psoriasis patients present with thyroid symptoms.
银屑病与甲状腺疾病之间的关联尚不清楚。
研究银屑病患者发生甲状腺疾病的风险。
我们使用台湾全民健康保险研究数据库进行了一项全国性队列研究。我们检测了银屑病和银屑病关节炎与甲状腺疾病发病风险的调整后危险比(aHR)和 95%置信区间(CI)。
我们确定了 13266 例银屑病关节炎患者(银屑病关节炎组)、149576 例单纯银屑病患者(银屑病组)和 162842 例非银屑病对照组。与非银屑病对照组相比,银屑病关节炎组和银屑病组发生甲亢的风险增加(aHR 1.32,95%CI 1.07-1.65[银屑病关节炎];aHR 1.22,95%CI 1.11-1.33[银屑病])和格雷夫斯病(aHR 1.38,95%CI 1.07-1.79[银屑病关节炎];aHR 1.26,95%CI 1.13-1.41[银屑病])。两组发生甲减的风险也增加(aHR 1.74,95%CI 1.34-2.27[银屑病关节炎];aHR 1.38,95%CI 1.23-1.56[银屑病])和桥本甲状腺炎(aHR 2.09,95%CI 1.34-3.24[银屑病关节炎];aHR 1.47,95%CI 1.18-1.82[银屑病])。
缺乏银屑病严重程度的数据。
患有银屑病的人发生甲状腺疾病的风险增加,包括甲亢、甲减、甲状腺炎、格雷夫斯病和桥本甲状腺炎。当银屑病患者出现甲状腺症状时,可考虑进行内分泌科会诊。